Brief: Turnstone Biologics Announces Strategic Restructuring To Prioritize Portfolio And Extend Financial Runway
11/10/2024 11:39
Turnstone Biologics Corp TSBX.O :
* TURNSTONE BIOLOGICS ANNOUNCES STRATEGIC RESTRUCTURING TO
PRIORITIZE PORTFOLIO AND EXTEND FINANCIAL RUNWAY
* TURNSTONE BIOLOGICS CORP - ANNOUNCES STRATEGIC
PRIORITIZATION
AND 60% WORKFORCE REDUCTION
* TURNSTONE BIOLOGICS CORP - REDUCING EMPLOYEE HEADCOUNT BY
APPROXIMATELY 60%
* TURNSTONE BIOLOGICS CORP - COST SAVINGS EXPECTED TO EXTEND
CASH
RUNWAY INTO 2Q 2026
* TURNSTONE BIOLOGICS CORP: VENKAT RAMANAN WILL BE STEPPING
DOWN
FROM HIS ROLE AS CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNX94SRC
Further company coverage: TSBX.O
Recent news on Turnstone Biologics
See all newsBrief: Turnstone Biologics to Be Acquired by XOMA for $0.34/Share Plus Contingent Value Right
U.S. STOCKS ON THE MOVE-Walmart, crypto, banks
Turnstone rises as company cuts job, changes executives
Brief: Turnstone Biologics Sees One-Time Severance-Related Charge Associated With Workforce Reduction To Be About $2.3 Million
Brief: Turnstone Biologics Announces Strategic Restructuring To Prioritize Portfolio And Extend Financial Runway